Prostate-specific antigen doubling time as a surrogate marker for evaluation of oncologic drugs to treat prostate cancer.

Authors

• Gary J Kelloff
• Donald S Coffey
• Bruce A Chabner
• Adam P Dicker
• Kathryn Z Guyton
• Perry D Nisen
• Howard R Soule
• Anthony V D'Amico

Publication/Presentation Date

6-1-2004

Volume

10

Issue

11

First Page

3927

Last Page

3933

ISSN

1078-0432

Published In/Presented At

Kelloff, G. J., Coffey, D. S., Chabner, B. A., Dicker, A. P., Guyton, K. Z., Nisen, P. D., Soule, H. R., & D'Amico, A. V. (2004). Prostate-specific antigen doubling time as a surrogate marker for evaluation of oncologic drugs to treat prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 10(11), 3927–3933. https://doi.org/10.1158/1078-0432.CCR-03-0788

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

15173102

Department(s)

Administration and Leadership

Document Type

Article